ASTCHIGH SIGNALFINANCIAL10-K

ASTC experienced severe operational deterioration with revenue declining 41% while operating cash flow worsened by 33% to -$13M, despite a significant cash infusion that boosted cash position by 973%.

The company appears to have raised capital (evidenced by the massive cash increase and higher liabilities) but is burning through it rapidly with worsening operational performance. The dramatic inventory reduction of 96% combined with falling revenue suggests either production issues or demand collapse, creating serious concerns about business viability.

Comparing 2025-09-26 vs 2024-09-20View on EDGAR →
FINANCIAL ANALYSIS

ASTC shows a company in financial distress despite recent capital raising - cash surged 973% to $35.9M while operating cash flow deteriorated 33% to -$13M annually. Revenue declined sharply by 41% to $1.0M with corresponding gross profit drops, while inventory plummeted 96% from $166K to just $7K, suggesting either severe demand issues or operational disruption. The combination of massive cash infusion, worsening operational metrics, and near-zero inventory levels signals a company struggling to maintain business operations despite access to capital.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
+973%
$3.3M$35.9M

Cash position surged 973% — strong cash generation or capital raise providing significant financial cushion.

Accounts Receivable
Balance Sheet
+529.9%
$77K$485K

Receivables surged 529.9% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.

Inventory
Balance Sheet
-95.8%
$166K$7K

Inventory drawn down 95.8% — strong sell-through or deliberate destocking; watch for supply constraints.

Total Liabilities
Balance Sheet
+72.6%
$2.8M$4.9M

Liabilities grew 72.6% — significant increase in debt or obligations, assess impact on financial flexibility.

Capital Expenditure
Cash Flow
+43.9%
$579K$833K

Capital expenditure jumped 43.9% — major investment cycle underway; assess returns on deployment.

Revenue
P&L
-41.2%
$1.7M$1.0M

Revenue declined 41.2% — significant demand weakness or market share loss warrants investigation.

Gross Profit
P&L
-36.8%
$751K$475K

Gross margin compression — rising input costs, pricing pressure, or unfavorable product mix shift.

Current Assets
Balance Sheet
-36.7%
$34.7M$22.0M

Current assets declined 36.7% — monitor working capital adequacy and short-term liquidity.

Stockholders Equity
Balance Sheet
-36.5%
$34.8M$22.1M

Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.

Operating Cash Flow
Cash Flow
-33.2%
-$9.7M-$13.0M

Operating cash flow fell 33.2% — earnings quality concerns; investigate working capital changes and non-cash items.

LANGUAGE CHANGES
NEW — 2025-09-26
PRIOR — 2024-09-20
ADDED
As of September 24, 2025, 1,758,953 shares of the registrant s common stock, par value $0.001 per share, were issued and outstanding.
Such risks and uncertainties include, but are not limited to: The adverse expectations regarding the global economy, inflation, the potential for recession and geopolitical tensions and any resulting sanctions, or wars; The effect of economic and political conditions in the United States or other nations that could impact our ability to sell our products and services or gain customers; Product demand and market acceptance risks, including our ability to develop and sell products and services to be used by governmental or commercial customers; The impact of trade barriers imposed by the U.S.
Although we believe that the assumptions underlying our forward-looking statements are reasonable, any of the assumptions could be inaccurate.
Our mission encompasses the advancement of both mass spectrometry and gas chromatography, two powerful analytical techniques that together enable precise detection and identification of chemical compounds across a wide range of high-demand environments.
We aim to expand access to mass spectrometry by simplifying the complexity of operating these devices within real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations.
+7 more — sign up free →
REMOVED
As of September 17, 2024, 1,701,729 shares of the registrant s common stock, par value $0.001 per share, were outstanding.
Our mission is to expand access to mass spectrometry ( MS ) and its use through the deployment of devices designed specifically for the appropriate levels of precision required in high-volume, real-time testing environments such as airports, border checkpoints, cargo hubs, infrastructure security, correctional facilities, military bases, law enforcement centers, and industrial locations.
We achieve our mission through simplifying the user interface, automating the complicated calibration process, ruggedizing the critical components to endure MS field work, and enabling multiple configurations for sample intake options.
Since the Tracer 1000 was certified by the European Civil Aviation Conference ( ECAC ) in 2019, our customers have deployed our devices in approximately 30 locations across 14 countries throughout Europe and Asia.
( Pro-Control ) is focused on applying the AMS Technology in industrial process control applications.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →